Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
42.43
-2.63 (-5.84%)
At close: Oct 28, 2026, 4:00 PM EDT
42.30
-0.13 (-0.31%)
After-hours: Oct 28, 2026, 7:59 PM EDT

Boston Scientific Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
5,1385,4425,2035,2865,0655,0614,6634,5614,2094,1203,8563,7253,5273,5993,3893,2423,1703,2443,0263,127
Revenue Growth (YoY)
1.44%7.53%11.58%15.90%20.34%22.84%20.93%22.44%19.34%14.48%13.78%14.90%11.26%10.94%12.00%3.68%8.12%5.43%9.96%15.43%
Cost of Revenue
1,7221,6061,6021,6141,5351,6511,4671,4751,3171,2791,2191,1581,1121,0701,0511,0249901,022967983
Gross Profit
3,4163,8363,6013,6723,5303,4103,1963,0862,8922,8412,6372,5672,4152,5292,3382,2182,1802,2222,0592,144
Selling, General & Admin
1,6831,8031,7811,8341,7411,7161,5971,6121,5621,4461,3641,3791,2421,3541,2151,1631,1321,1651,0601,153
Research & Development
520554516569514526443459407383366363356359337330339335319320
Amortization of Goodwill & Intangibles
234233232228225225219225205213214208208210203199202204198192
Operating Expenses
2,4372,5902,5292,6312,4802,4672,2592,2962,1742,0421,9441,9501,8061,9231,7551,6921,6731,7041,5771,665
Operating Income
9791,2461,0721,0411,050943937790718799693617609606583526507518482479
Interest Expense
-100-96-90-90-87-90-82-80-79-77-69-65-66-70-65-64-63-64-279-87
Interest & Investment Income
-11-29-3-107---95--10---1
Currency Exchange Gain (Loss)
--15-11--12---5-4-1-5-11-6-9-1414-381-9-10
Other Non Operating Income (Expenses)
5-62828-16-11-27-53189-426-13-11-628-15-10-16-6
EBT Excluding Unusual Items
8841,1409991,008935845828759653730615576529516498514391445178377
Merger & Restructuring Charges
-63-8-3-168-83-10-4-8-1-3-18-15-16-20-6-4-11-4-22
Gain (Loss) on Sale of Investments
--121371396220-8-621-3114-38-22-2173-4-742
Gain (Loss) on Sale of Assets
----------------22---30
Asset Writedown
-39-----46--110--276---1-57---125-7--197
Legal Settlements
-81-76--194--------111---131--42--128
Other Unusual Items
321630-237-115-5123-2-17-15-12-19-1233-20-36-1219
Pretax Income
7331,0601,163700938941805584669420609505610426445395245345155121
Income Tax Expense
153155-176301831461332320098115110515613125557854526
Earnings From Continuing Operations
5809051,33967075579567256146932249450450527031414018826011095
Minority Interest in Earnings
2222-224-211--------
Net Income
5829071,34167275579767456546932449550550527031414018826011095
Preferred Dividends & Other Adjustments
-------------9141414141415
Net Income to Common
5829071,3416727557976745654693244955055052613001261742469680
Net Income Growth (YoY)
-22.91%13.80%98.96%18.94%60.98%145.99%36.16%11.88%-7.13%24.14%65.00%300.79%190.23%6.10%212.50%57.50%-57.04%43.02%-70.64%-59.18%
Shares Outstanding (Basic)
1,4491,4701,4851,4831,4821,4801,4771,4741,4731,4711,4681,4651,4651,4461,4361,4331,4321,4301,4281,425
Shares Outstanding (Diluted)
1,4521,4751,4951,4961,4961,4941,4931,4901,4871,4841,4821,4771,4751,4561,4461,4421,4401,4381,4381,436
Shares Change (YoY)
-2.91%-1.25%0.13%0.38%0.55%0.63%0.77%0.90%0.84%1.92%2.47%2.39%2.43%1.28%0.53%0.43%0.31%0.37%0.53%-0.30%
EPS (Basic)
0.400.620.900.450.510.540.460.380.320.220.340.340.340.180.210.090.120.170.070.06
EPS (Diluted)
0.400.610.900.450.510.530.450.380.320.220.330.340.340.180.210.090.120.170.070.06
EPS Growth (YoY)
-21.50%15.09%100.00%18.54%60.00%140.91%36.36%11.98%-6.33%22.22%57.94%285.57%183.33%5.88%210.76%56.67%-57.14%41.67%-70.77%-59.06%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-1,2791711,0131,1621,1293541,179823658-1569050851579595320202-179212
Free Cash Flow Per Share
-0.870.110.680.780.760.240.790.550.44-0.010.470.340.350.060.410.220.14-0.120.15
Gross Margin
66.48%70.49%69.21%69.47%69.69%67.38%68.54%67.66%68.71%68.96%68.39%68.91%68.47%70.27%68.99%68.42%68.77%68.50%68.04%68.56%
Operating Margin
19.05%22.90%20.60%19.69%20.73%18.63%20.09%17.32%17.06%19.39%17.97%16.56%17.27%16.84%17.20%16.23%15.99%15.97%15.93%15.32%
Profit Margin
11.33%16.67%25.77%12.71%14.91%15.75%14.45%12.39%11.14%7.86%12.84%13.56%14.32%7.25%8.85%3.89%5.49%7.58%3.17%2.56%
Free Cash Flow Margin
-23.50%3.29%19.16%22.94%22.31%7.59%25.85%19.55%15.97%-0.39%18.52%14.40%14.31%2.33%18.35%10.10%6.23%-5.92%6.78%
EBITDA
1,3341,6011,4231,4061,3921,2791,2621,1381,0241,110997930909904868820791802756769
EBITDA Margin
25.96%29.42%27.35%26.60%27.48%25.27%27.06%24.95%24.33%26.94%25.86%24.97%25.77%25.12%25.61%25.29%24.95%24.72%24.98%24.59%
D&A For EBITDA
355355351365342336325348306311304313300298285294284284274290
EBIT
9791,2461,0721,0411,050943937790718799693617609606583526507518482479
EBIT Margin
19.05%22.90%20.60%19.69%20.73%18.63%20.09%17.32%17.06%19.39%17.97%16.56%17.27%16.84%17.20%16.23%15.99%15.97%15.93%15.32%
Effective Tax Rate
20.87%14.62%-4.29%19.51%15.52%16.52%3.94%29.89%23.33%18.88%0.20%17.21%36.62%29.44%64.56%23.27%24.64%29.03%21.49%
SEC Filings: 10-K · 10-Q